BASSETTI GROUP acquires the German software provider MAQSIMA
In the context of its extensive growth and internationalization strategy, the BASSETTI Group announces the acquisition of the German software provider MAQSIMA. This strategic acquisition is a further chapter in BASSETTI’s dynamic external expansion, which aims to strengthen its market presence in France and abroad.
Founded in France in 1992, the BASSETTI Group has become a world leader in software solutions for the management of technical and scientific data for industry and research. With an excellent reputation for innovative solutions in quality management, regulatory compliance and data security, the BASSETTI Group has significantly expanded its global footprint through strategic partnerships and targeted acquisitions, with the support of its minority shareholder Siparex Midcap since 2022.
The acquisition of MAQSIMA represents a further decisive step in BASSETTI’s external growth strategy. Founded in 1999 and based in Sulzbach (Germany), near the French border, the Saarland-based company is known throughout Germany for its expertise in the development of state-of-the-art LIMS and TMS solutions. In its 25-year history, the company has developed into the market leader for solutions in the pharmaceutical/life science sector. With this acquisition, BASSETTI strengthens its position in the European market by expanding its product portfolio and drawing on MAQSIMA’s technological know-how. The MAQSIMA LAB+, MAQSIMA TMS, and MAQSIMA myFM software solutions, combined with BASSETTI’s data management ecosystem, will represent the most comprehensive suite of tools on the market for laboratory process optimization, regulatory compliance and product quality improvement.
Moreover, the acquisition will allow BASSETTI to expand its presence specifically in the German market, which is not only the largest in Europe, but also represents an important innovation center for laboratory technology. By integrating MAQSIMA’s team of highly qualified employees, BASSETTI further strengthens its research and development capabilities, which will enable the company to drive continued innovation and meet changing customer needs at all times.
David Bassetti (Founder & Managing Director – BASSETTI Group): “I am more than happy that with MAQSIMA we were able to win a renowned software provider and German market leader in the pharma/life science sector for the BASSETTI Group. With this acquisition, we are enhancing our product portfolio with a strong solution for validation-critical industries and can offer our customers the most comprehensive software suite on the market. The acquisition also enables us to further expand our market position in Germany – the largest industrial nation in Europe with enormous potential – and gain strategic resources and expertise in a competitive labor market. From the very first meeting, it was clear to me that there is a very strong fit in terms of products, people and corporate culture, which will create far-reaching synergies between MAQSIMA and the BASSETTI Group.”
The takeover was also eagerly awaited by the management of MAQSIMA, as the mutual benefits and synergies are clear to see: Christoph Niewöhner (Managing Partner – MAQSIMA): “In all the talks and meetings I’ve had so far, I’ve gotten to know BASSETTI and its employees as a company with fantastic and likable people. This positive feeling turns into strong excitement when I look at the opportunities and synergies that will arise for us by becoming part of the BASSETTI Group. As a company that is only a 10-minute drive from the French border and possesses a strong market penetration in Germany, future internationalization is the next important step for us to grow further. BASSETTI’s international network with branches in Europe, America, Asia and Africa is the perfect partner to better serve existing and future customers with worldwide locations. I particularly see the collaboration and use of synergies in the research and development departments as a great opportunity, especially in the areas of cloud and artificial intelligence, which will be the most important future topics in the coming years.”
The acquisition was furthermore brought about by a very close exchange and pragmatic negotiations with the former owner CERTINA Group. Giovanni Santamaria (Managing Partner IT – CERTINA Group): “We are very pleased that the acquisition has come to fruition and are convinced that MAQSIMA will continue to develop successfully within the BASSETTI Group. We have accompanied the company in its growth over the last 18 years and can hand it over to BASSETTI with a clear conscience. By grouping together specialist software from Europe and worldwide, we see enormous growth opportunities in BASSETTI’s network, both geographically and in terms of the product portfolio. We believe that MAQSIMA’s solutions fit perfectly into BASSETTI’s product and development strategy, particularly due to their extensive expertise in the pharmaceutical sector. We would like to thank everyone involved for the extremely pleasant, goal-oriented and pragmatic discussions and would welcome the opportunity to do business with Bassetti again at any time.”
Augustin de Jerphanion and Yann Rinckenberger (Partners – SIPAREX Midcap): “The acquisition of Maqsima perfectly illustrates BASSETTI’s ability to integrate complementary targets, as well as their teams ! After establishing itself as a leading LIMS provider in France, the BASSETTI Group and David BASSETTI are implementing a strong international development (already 25% of the turnover) accelerated by the investment of Siparex Private Equity Midcap fund since 2022. BASSETTI has thus become a true consolidation platform, which aims at quickly integrating new targets in Europe and North America.”
For the BASSETTI Group, this acquisition marks the beginning of a new stage of growth and expansion. Building on its reputation for technical excellence and our commitment to innovation, the Group is determined to continue its expansion in international markets by offering cutting-edge technology solutions that meet the most complex challenges of today’s industry.
With this acquisition, BASSETTI further underlines its commitment to innovation and its ambition to remain at the forefront of digital transformation in the field of technical and scientific data management. With MAQSIMA at its side, the Group is ideally positioned to push the boundaries of what is technologically possible and create strong value for its customers around the world.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
